Skip to content

Subscriptions are live.

Plans
Logo

Why is $QURE stock up today?

uniQure N.V. · PHARMACEUTICAL PREPARATIONS

Why is $QURE up today?

The likely driver

uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease
uniQure N.V.: uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease
SEC filing · Sep 2
Price
$45.35
Move today
+2.3%
Volume vs avg
0.0x
Scanner alerts today
3
Flagged in 30 days
192
Market cap
$3.1B
Prev close
$44.31
Avg volume
1.4M

Today’s scanner timeline

  • 3:34 PMUnusual volume (RVOL) alert
  • 1:39 PMUnusual volume (RVOL) alert
  • 12:47 PMUnusual volume (RVOL) alert

Unusual-volume alerts often fire before the news is widely reported. This is when our scanner first flagged QURE today.

Earlier scanner activity on QURE

  • Sep 21Unusual volume (RVOL) alert
  • Sep 21Unusual volume (RVOL) alert
  • Sep 21Big % mover alert
  • Sep 21Unusual volume (RVOL) alert
  • Sep 21Big % mover alert
  • Sep 21Big % mover alert
  • Sep 21Big % mover alert
  • Sep 21Unusual volume (RVOL) alert
  • Sep 21Big % mover alert
  • Sep 21Big % mover alert
  • Sep 18Big % mover alert
  • Sep 18Big % mover alert

Prior sessions in the last 30 days. A name our scanner keeps flagging is behaving differently from the rest of the market, even on a quiet day.

Free alerts

Get free $QURE alerts the moment volume spikes

Our scanner flagged $QURE 3 times in the last 30 days. Create a free account to track $QURE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Other stocks moving today

Each opens that stock’s own why-is-it-moving page.

Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.